Herskowitz Neil

Average Profitability
75.59%
Insider Buys Quantity
27
Insider Buys Sum
$440,364.74
Insider Sells Quantity
1
Insider Sells Sum
$46.00

Insider Activity of Herskowitz Neil

According to the SEC Form 4 filings, Herskowitz Neil, being in a position of

  1. director at Avenue Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 23 shares for $46,
    over all time since 2017-10-09, has bought 50061 share for $321,815, and sold 23 shares for $46.

The largest purchase of all time was on 2020-02-25 and amounted to 10000 shares of Avenue Therapeutics, Inc. for $93,100.

The largest sale of all time was on 2024-12-02 and amounted to 23 shares of Avenue Therapeutics, Inc. for $46.

Biography of Herskowitz Neil

No biography is available at this moment.

2024-12-02SaleAvenue Therapeutics, Inc.
ATXI
director
23
0.0012%
$2.00$46-5.67%
2021-05-06PurchaseAvenue Therapeutics, Inc.
ATXI
director
2,500
0.0142%
$3.99$9,975-68.56%
2020-02-27PurchaseAvenue Therapeutics, Inc.
ATXI
director
2,400
0.0139%
$8.20$19,680+3.72%
2020-02-26PurchaseAvenue Therapeutics, Inc.
ATXI
director
161
0.001%
$8.73$1,406+0.45%
2020-02-25PurchaseAvenue Therapeutics, Inc.
ATXI
director
10,000
0.0629%
$9.31$93,100-0.89%
2019-06-18PurchaseAvenue Therapeutics, Inc.
ATXI
director
2,000
0.0126%
$5.83$11,660+21.09%
2019-06-17PurchaseAvenue Therapeutics, Inc.
ATXI
director
3,000
0.0182%
$5.88$17,640+15.92%
2019-04-15PurchaseAvenue Therapeutics, Inc.
ATXI
director
1,000
0.0061%
$4.52$4,520+33.63%
2019-03-29PurchaseAvenue Therapeutics, Inc.
ATXI
director
1,400
0.011%
$5.11$7,154+26.95%
2019-03-28PurchaseAvenue Therapeutics, Inc.
ATXI
director
600
0.0044%
$5.11$3,066+17.91%
2019-02-25PurchaseAvenue Therapeutics, Inc.
ATXI
director
5,000
0.0378%
$5.46$27,300+12.67%
2019-02-05PurchaseAvenue Therapeutics, Inc.
ATXI
director
1,850
0.0128%
$5.77$10,675-3.22%
2019-02-04PurchaseAvenue Therapeutics, Inc.
ATXI
director
7,000
0.0505%
$5.91$41,370-1.59%
2019-01-30PurchaseAvenue Therapeutics, Inc.
ATXI
director
650
0.0045%
$5.91$3,842-5.71%
2019-01-29PurchaseAvenue Therapeutics, Inc.
ATXI
director
8,553
0.0623%
$5.91$50,548-0.59%
2019-01-28PurchaseAvenue Therapeutics, Inc.
ATXI
director
1,447
0.0104%
$5.84$8,450-0.42%
2018-11-23PurchaseMustang Bio, Inc.
MBIO
director
1,000
0.0002%
$3.96$3,960-17.11%
2018-04-25PurchaseAvenue Therapeutics, Inc.
ATXI
director
1,000
0.0094%
$3.80$3,800+5.32%
2017-10-17PurchaseAvenue Therapeutics, Inc.
ATXI
director
1,000
0.0097%
$5.01$5,010-23.94%
2017-10-09PurchaseAvenue Therapeutics, Inc.
ATXI
director
500
0.0051%
$5.24$2,620-22.85%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.